Laboratory News and Research

RSS

Research into hospital bed technology could soon represent giant leap forward in patient care

A University of New Hampshire professor's research into hospital bed technology could soon represent a giant leap forward in patient care.

9 Dec 2010

Agilent, UC Davis to develop MassCode PCR technology for identifying food-borne pathogens

Agilent Technologies Inc. today announced it is collaborating with the University of California, Davis in the area of food safety. The research collaboration will focus on the development of a new process that can reduce the time required to identify food-borne pathogens from several days to only a few hours.

9 Dec 2010

New objective criteria for evaluating hemostatic efficacy in treatment of VWD

Octapharma USA researchers presented new stringent, objective criteria used in the evaluation of hemostatic efficacy in the treatment of von Willebrand disease and reported on their application of these criteria in clinical trials during the recently completed National Hemophilia Foundation Annual Meeting.

9 Dec 2010

AltheaDx partners with Compendia Bioscience to launch Breast Cancer Segregation Panel Assay

AltheaDx, Inc. today announced the formation of a strategic partnership with Compendia Bioscience to combine their respective core capabilities in assay development, validation and bioinformatics. The two companies will jointly create novel products and services focused on cancer biomarker discovery and subsequent development of tests that predict patient outcomes in clinical trials.

9 Dec 2010

MedeAnalytics introduces Accountable Care Solution for healthcare provider and payer organizations

MedeAnalytics, a leading provider of healthcare performance management solutions, today announced the launch of its Accountable Care Solution for healthcare provider and payer organizations.

8 Dec 2010

Low-dose diazepam with NS-398 combination has twice the neuroprotective effect of NS-398 alone

Status epilepticus, prolonged seizures, can lead to significant neurological deficits and, rarely, even death. The anticonvulsant diazepam, a first line therapy for the condition, is neuroprotective when administered in high doses within two hours from seizure onset. Researchers at the 64th AES Annual Meeting now report that the combination of low-dose diazepam and NS-398, a COX-2 inhibitor, has twice the neuroprotective effect of NS-398 alone.

8 Dec 2010

Small molecules show promise in protecting brain cells against nerve-degenerative diseases

Investigators at Southern Methodist University and The University of Texas at Dallas have discovered a family of small molecules that shows promise in protecting brain cells against nerve-degenerative diseases such as Parkinson's, Alzheimer's and Huntington's, which afflict millions.

8 Dec 2010

American Society for Microbiology honors UTHealth biologist for significant contributions

Known nationally for her research into single-cell organisms that affect oral health, Millicent "Mimi" Goldschmidt, Ph.D., a professor of microbiology and molecular genetics at The University of Texas Health Science Center at Houston (UTHealth), has been selected to receive the 2011 American Society for Microbiology (ASM) Founders Distinguished Service Award.

8 Dec 2010

Ultraviolet light activates enzyme that helps skin cancer cells survive, proliferate: Researchers

The sun's ultraviolet light activates an enzyme that helps skin cancer cells survive and proliferate, researchers report.

8 Dec 2010

Scientists work together to wipe out some of the most lethal diseases

Scientists at Seattle Biomedical Research Institute and Northwestern University Feinberg School of Medicine have reached a major milestone in the effort to wipe out some of the most lethal diseases on the planet. As leaders of two large structural genomics centers, they've experimentally determined 500 three-dimensional protein structures from a number of bacterial and protozoan pathogens, which could potentially lead to new drugs, vaccines and diagnostics to combat deadly infectious diseases.

8 Dec 2010

New technique may help develop novel treatments for brain diseases

Scientists have created a way to isolate neural stem cells - cells that give rise to all the cell types of the brain - from human brain tissue with unprecedented precision, an important step toward developing new treatments for conditions of the nervous system, like Parkinson's and Huntington's diseases and spinal cord injury.

8 Dec 2010

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

Celator Pharmaceuticals today announced positive clinical data in elderly patients with newly-diagnosed acute myeloid leukemia (AML) treated with CPX-351 (Cytarabine:Daunorubicin) Liposome Injection. Data were presented from the podium at the 52nd American Society of Hematology (ASH) Annual Meeting in Orlando, Florida.

8 Dec 2010

NIH awards Scripps Research $2.35M to study new treatment for obesity

The Scripps Research Institute has been awarded a $2.35 million grant from the National Institutes of Health to study a new way of treating obesity as part of a national consortium with the Dana-Farber Cancer Institute.

8 Dec 2010

Concentrated nicotine in E-cigarattes poses unknown risks to consumers

What do some pesticides and "electronic cigarettes" have in common? According to a new report published in the American Journal of Public Health, the answer is unregulated concentrations of nicotine that may pose unknown risks to consumers who are exposed to them.

8 Dec 2010

eLINCx to implement GE's eHealth Information Exchange across Wooster, Dunlap Community Hospitals

eLINCx, founded earlier this year to provide quality healthcare services to central Ohio communities, and GE Healthcare announced today that eLINCx will implement GE Healthcare's eHealth Information Exchange across Wooster Community Hospital, Dunlap Community Hospital and more than a dozen physician practices.

7 Dec 2010

Contrave, new weight loss pill gets FDA panel nod

A Food and Drug Administration (FDA) panel yesterday recommended the approval of Orexigen Therapeutics’ weight loss drug Contrave. This is the first time a weight loss drug has received the nod. The vote went 13 to 7 for Contrave’s approval and 11 to 8, with an abstention that additional studies be conducted on heart risks. Although experts agree to risks they believe the benefits outweigh the risks. Although the FDA is not compelled to go with the panel’s recommendation, it more often than not does. The FDA will deliver its verdict by Jan. 31 2011.

7 Dec 2010

Size exclusion chromatography illuminates protein crystallization

Understanding membrane protein crystallization is one of the main goals of molecular biology studies aimed at the structural characterization of proteins.

From Malvern Panalytical 7 Dec 2010

FEI launches Magellan extreme resolution scanning electron microscope for life science imaging

FEI Company, a leading instrumentation company providing electron microscope systems for applications in research and industry, today announced the Magellan™ extreme resolution scanning electron microscope (SEM) optimized specifically for life science imaging. The first of its kind, the Magellan SEM enables life science researchers and cell biologists to actually view the entire organization of a cell in its natural, fully-hydrated state.

7 Dec 2010

Lutheran Medical Center implements Medsphere's OpenVista EHR solution

Lutheran Medical Center (LMC) and Medsphere Systems Corporation today announced the successful implementation of Medsphere's OpenVista® electronic health record (EHR) solution throughout the hospital. The full service 476-bed teaching hospital is now on track to achieve meaningful use and qualify for millions of dollars made available by the American Recovery and Reinvestment Act of 2009.

7 Dec 2010

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

GenVec, Inc. announced today that data were presented on GenVec's respiratory syncytial virus (RSV) vaccine program at the International Respiratory Syncytial Virus Symposium, which took place in Rotterdam, Netherlands on December 2-5, 2010. The presentation was given by Barney S. Graham, MD, PhD, Chief, Viral Pathogenesis Laboratory and Chief, Clinical Trials Core, at the Vaccine Research Center (VRC) of the National Institutes of Health (NIH).

7 Dec 2010

Laboratory News and Research

Research into hospital bed technology could soon represent giant leap forward in patient care

Agilent, UC Davis to develop MassCode PCR technology for identifying food-borne pathogens

New objective criteria for evaluating hemostatic efficacy in treatment of VWD

AltheaDx partners with Compendia Bioscience to launch Breast Cancer Segregation Panel Assay

MedeAnalytics introduces Accountable Care Solution for healthcare provider and payer organizations

Low-dose diazepam with NS-398 combination has twice the neuroprotective effect of NS-398 alone

Small molecules show promise in protecting brain cells against nerve-degenerative diseases

American Society for Microbiology honors UTHealth biologist for significant contributions

Ultraviolet light activates enzyme that helps skin cancer cells survive, proliferate: Researchers

Scientists work together to wipe out some of the most lethal diseases

New technique may help develop novel treatments for brain diseases

Positive data from Celator's CPX-351 Phase 2 study in newly-diagnosed AML presented at 52nd ASH

NIH awards Scripps Research $2.35M to study new treatment for obesity

Concentrated nicotine in E-cigarattes poses unknown risks to consumers

eLINCx to implement GE's eHealth Information Exchange across Wooster, Dunlap Community Hospitals

Contrave, new weight loss pill gets FDA panel nod

Size exclusion chromatography illuminates protein crystallization

FEI launches Magellan extreme resolution scanning electron microscope for life science imaging

Lutheran Medical Center implements Medsphere's OpenVista EHR solution

Encouraging GenVec RSV vaccine program data presented at International Respiratory Syncytial Virus Symposium

Lab Diagnostics and Automation - Second Edition eBook

Discover how SciY empowers scientists

Why use light scattering to analyze proteins and viral vectors?

Changing the landscape of R&D to build clinical success from the ground up

Latest Life Science News